Tago, Elizabeth B.
HRN: 25-06-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2024
CEFUROXIME 500MG (TAB)
05/25/2024
06/01/2024
PO
1 Tab
BID
SP NSVD W RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes